A New Dimension in Potency Testing
Traditional potency assays often take days or even weeks to yield results. This lag can slow decisions during development and manufacturing. A promising innovation is the real-time detection of free radicals and their kinetics.
Free radicals, or reactive oxygen species (ROS), are key indicators of cellular activity. Measuring them live and dynamically offers a faster, more sensitive, and more mechanistic readout of potency.
Why Free Radical Detection Matters
- Speed – Results in minutes to hours, compared to multi-day assays.
- Early functional insight – ROS signals reveal biological activity as it happens.
- Sensitivity – Subtle differences in drug action can be captured in real time.
- Mechanistic link – ROS dynamics often correlate directly with therapeutic mechanism.
- ncy.
Case Applications
- Gene Therapy (AAV vectors): Transduction triggers oxidative stress. ROS kinetics can act as a surrogate marker of transduction efficiency, complementing ELISA or ddPCR.
- mRNA Vaccines & Therapeutics: Translation of mRNA causes transient oxidative bursts. Monitoring ROS provides an early signal of protein expression, faster than traditional assays.
- Monoclonal Antibodies (mAbs): Immune functions like ADCC involve ROS. Free radical kinetics can serve as a biomarker of immune potency, beyond binding measurements.
From Retrospective to Predictive
With live free radical detection, potency assays are evolving from retrospective checks to predictive, rapid, and mechanism-linked tools. This approach strengthens control strategies, supports faster release, and accelerates time-to-patient.
The Takeaway
By integrating free radical detection and kinetic profiling into potency assays, developers gain faster, more actionable insights. It’s a step forward in ensuring that biopharmaceutical products are not only consistent and safe but also functionally effective in real time.
Share this:
